Skip to main content

Table 4 Possible risk factors for remifentanil-induced chest wall rigidity based on logistic regression analysis

From: The effects of the administration sequence and the type of hypnotics on the development of remifentanil-induced chest wall rigidity: a randomized controlled trial

 

Univariate analysis

Crude OR [95% CI]

P value

\(\ge\) 75 years

1.85 [0.77–4.45]

0.170

Female sex

1.10 [0.52–2.35]

0.807

Remifentanil-hypnotic order

4.42 [1.99–9.81]

 < 0.001*

Propofol usage

0.751 [0.36–1.58]

0.453

BMI (kg/m2)

1.06 [0.95–1.19]

0.315

Percent body fat (%)

1.00 [0.96–1.05]

0.848

Skeletal muscle index (kg/m2)

1.12 [0.84–1.50]

0.437

  1. *Compared with the hypnotic-remifentanil sequence